These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3093566)

  • 21. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression.
    Ledbetter JA; Rose LM; Spooner CE; Beatty PG; Martin PJ; Clark EA
    J Immunol; 1985 Sep; 135(3):1819-25. PubMed ID: 3160781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
    J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
    Abo T; Miller CA; Balch CM; Cooper MD
    J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for negative regulation of T cell growth by low affinity interleukin 2 receptors.
    Kumar A; Moreau JL; Baran D; Thèze J
    J Immunol; 1987 Mar; 138(5):1485-93. PubMed ID: 3100639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.
    Baroja ML; Ceuppens JL; Van Damme J; Billiau A
    J Immunol; 1988 Sep; 141(5):1502-7. PubMed ID: 3261751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R; Crow MK; Russo C; Weksler ME
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations.
    Malek TR; Schmidt JA; Shevach EM
    J Immunol; 1985 Apr; 134(4):2405-13. PubMed ID: 3919092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD; Lipsky PE
    J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
    Kelley VE; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):617. PubMed ID: 3274827
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice.
    Titus RG; Ceredig R; Cerottini JC; Louis JA
    J Immunol; 1985 Sep; 135(3):2108-14. PubMed ID: 3926895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
    J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G; Hu J; Zhou G; Zhu J; Sun Q
    Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.